This comprehensive volume aims to advance knowledge and strategies to combat tuberculosis, aligning with the World Health Organization's goal of eradicating TB by 2035 by addressing the need for up-to-date information on host-pathogen interactions in tuberculosis and incorporating the latest research findings and advancements. It highlights emerging therapeutic targets among host and TB pathogen proteins and integrates multidisciplinary approaches from microbiology, immunology, and molecular biology, offering a holistic perspective on TB pathophysiology. Researchers will find detailed discussions on key host proteins involved in tuberculosis pathogenesis, the molecular tactics employed by M. tb to subvert host defenses, and host-mediated inhibition strategies targeting M. tb.
Table of Contents
SECTION I: Mycobacterial virulence and host interaction1. Mechanisms of Mycobacterium tuberculosis virulence: The ESX1 locus and host countermeasures
2. Mycobacterial PE/PPE proteins: Key regulators of apoptosis and pathogenic outcomes
3. Unraveling Mycobacterium tuberculosis pathogenesis: Insights into PE/PPE proteins from a molecular viewpoint
4. Host-pathogen dynamics in Mycobacterium tuberculosis: The impact of PE/PPE proteins on innate and adaptive immunity
SECTION II: Host defense mechanisms and cellular responses
5. Mechanisms of phagosomal damage detection and response to Mycobacterium tuberculosis: Repair, autophagy, and biogenesis
6. Autophagy and Mycobacterium tuberculosis: Host defense mechanisms versus pathogen evasion
7. Unraveling NCoR1’s role in Mycobacterium tuberculosis pathogenicity
8. Division: An eternal rhythm of the cells
9. Programmed cell death during Mycobacterium tuberculosis infection: The roles of pyroptosis and necroptosis in host defense
10. Unraveling the cellular battlefield: Mycobacterium tuberculosis and its interplay with host cell death pathways
SECTION III: Therapeutic frontiers and drug repurposing
11. Repurposing potential of cell wall-modulating drugs: A new frontier in TB management
12. Metabolic repurposing in Mycobacterium-infected macrophages: A strategy for enhanced virulence and survival
13. Revolutionizing TB therapy: Emerging opportunities and unresolved challenges
SECTION IV: Nutrition, immunity, and broader mycobacterial contexts
14. The enigma of food supplementation in TB: A role for unresolved inflammation
15. Immunological insights: How macrophages combat non-tuberculous mycobacteria
16. Extra-Pulmonary tuberculosis: Insights into mitigation and control
17. Multifaceted approaches to tuberculosis management: Bridging molecular discovery and public health impact

